Ten-year follow-up results from the Goettingen risk, incidence and prevalence study (GRIPS) .1. Risk factors for myocardial infarction in a cohort of 5790 men

被引:94
作者
Cremer, P [1 ]
Nagel, D [1 ]
Mann, H [1 ]
Labrot, B [1 ]
MullerBerninger, R [1 ]
Elster, H [1 ]
Seidel, D [1 ]
机构
[1] VOLKSWAGEN AG, WERK KASSEL, D-34219 BAUNATAL, GERMANY
关键词
prospective cohort study; coronary risk factors; myocardial infarction; LDL cholesterol; CORONARY HEART-DISEASE; ARTERY DISEASE; CARDIOVASCULAR-DISEASE; A-I; CHOLESTEROL; APOLIPOPROTEINS; LIPOPROTEIN(A); FIBRINOGEN; THERAPY; ATHEROSCLEROSIS;
D O I
10.1016/S0021-9150(96)06030-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Besides the accepted major risk factors for myocardial infarction (MI), cholesterol, hypertension and smoking, several other variables such as lipoproteins, apolipoproteins, fibrinogen and family history of MI, have been considered, but their usefulness as predictors of MI is controversially discussed. The Gottingen Risk Incidence and Prevalence Study (GRIPS) aimed to evaluate the independent impact of the latter in comparison to the established risk factors. GRIPS is a prospective cohort study, which included 5790 men, aged 40-59.9 years, without cardiovascular disease at baseline. Multivariate logistic regression models for the estimation of the MI risk based on the 10-year follow-up data from 97.4% of the study participants established LDL cholesterol as the strongest predictor of MI. It was followed by family history of MI, Lp(a), age, smoking, systolic blood pressure, HDL cholesterol (inversely related) and plasma glucose (P < 0.001). Apolipoprotein B as well as the ratios total/HDL cholesterol, LDL/HDL cholesterol and Apo B/AI were less effective predictors than LDL cholesterol and did not contribute independently to the estimation of MI risk. Similarly apoprotein AI was a weaker predictor of MI risk then HDL cholesterol. GRIPS is the first prospective cohort study which clearly justifies the key role of LDL cholesterol in preventive strategies. However, the data also give strong support for the additional consideration of other risk factors for a valid estimation of the MI risk for an individual subject. (C) 1997 Elsevier Science Ireland Ltd.
引用
收藏
页码:221 / 230
页数:10
相关论文
共 39 条
  • [1] THE EFFECT OF CHOLESTEROL-LOWERING AND ANTIOXIDANT THERAPY ON ENDOTHELIUM-DEPENDENT CORONARY VASOMOTION
    ANDERSON, TJ
    MEREDITH, IT
    YEUNG, AC
    FREI, B
    SELWYN, AP
    GANZ, P
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (08) : 488 - 493
  • [2] [Anonymous], 1993, JAMA, V269, P505
  • [3] [Anonymous], 1991, Modelling binary data, DOI DOI 10.1007/978-1-4899-4475-7
  • [4] AVOGARO P, 1979, LANCET, V1, P901
  • [5] THE ELECTROCARDIOGRAM IN POPULATION STUDIES - A CLASSIFICATION SYSTEM
    BLACKBURN, H
    KEYS, A
    SIMONSON, E
    RAUTAHARJU, P
    PUNSAR, S
    [J]. CIRCULATION, 1960, 21 (06) : 1160 - 1175
  • [6] A PROSPECTIVE INVESTIGATION OF ELEVATED LIPOPROTEIN(A) DETECTED BY ELECTROPHORESIS AND CARDIOVASCULAR-DISEASE IN WOMEN - THE FRAMINGHAM HEART-STUDY
    BOSTOM, AG
    GAGNON, DR
    CUPPLES, LA
    WILSON, PWF
    JENNER, JL
    ORDOVAS, JM
    SCHAEFER, EJ
    CASTELLI, WP
    [J]. CIRCULATION, 1994, 90 (04) : 1688 - 1695
  • [7] SUMMARY ESTIMATES OF CHOLESTEROL USED TO PREDICT CORONARY HEART-DISEASE
    CASTELLI, WP
    ABBOTT, RD
    MCNAMARA, PM
    [J]. CIRCULATION, 1983, 67 (04) : 730 - 734
  • [8] LIPOPROTEIN LP(A) AS PREDICTOR OF MYOCARDIAL-INFARCTION IN COMPARISON TO FIBRINOGEN - LDL CHOLESTEROL AND OTHER RISK-FACTORS - RESULTS FROM THE PROSPECTIVE GOTTINGEN RISK INCIDENCE AND PREVALENCE STUDY (GRIPS)
    CREMER, P
    NAGEL, D
    LABROT, B
    MANN, H
    MUCHE, R
    ELSTER, H
    SEIDEL, D
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1994, 24 (07) : 444 - 453
  • [9] CREMER P, 1991, GOTTINGER RISIKO INZ
  • [10] PLASMA TRIGLYCERIDE LEVEL AND MORTALITY FROM CORONARY HEART-DISEASE
    CRIQUI, MH
    HEISS, G
    COHN, R
    COWAN, LD
    SUCHINDRAN, CM
    BANGDIWALA, S
    KRITCHEVSKY, S
    JACOBS, DR
    OGRADY, HK
    DAVIS, CE
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (17) : 1220 - 1225